Carvotroline

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCarvotroline

Drug Alias NameCarvotroline hydrochlorideWY-47791

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists

TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor

Therapy Area/IndicationsMental Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsMental Disorders

ATC CodeN/A